These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36868056)

  • 1. Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.
    Hilmi M; Kamal M; Vacher S; Dupain C; Ibadioune S; Halladjian M; Sablin MP; Marret G; Ajgal ZC; Nijnikoff M; Salomon A; El Beaino Z; Servant N; Dureau S; Sokol H; Nicolle R; Le Tourneau C; Bieche I; Neuzillet C
    Eur J Cancer; 2023 Apr; 183():152-161. PubMed ID: 36868056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
    Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
    Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed Characterization of the Lung-Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients.
    Ankudavicius V; Nikitina D; Lukosevicius R; Tilinde D; Salteniene V; Poskiene L; Miliauskas S; Skieceviciene J; Zemaitis M; Kupcinskas J
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies.
    Chen Z; Radjabzadeh D; Chen L; Kurilshikov A; Kavousi M; Ahmadizar F; Ikram MA; Uitterlinden AG; Zhernakova A; Fu J; Kraaij R; Voortman T
    JAMA Netw Open; 2021 Jul; 4(7):e2118811. PubMed ID: 34323983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival.
    Peters BA; Hayes RB; Goparaju C; Reid C; Pass HI; Ahn J
    Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):731-740. PubMed ID: 30733306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of genomic and transcriptional microbiome analysis in gastric cancer patients and healthy individuals.
    Nikitina D; Lehr K; Vilchez-Vargas R; Jonaitis LV; Urba M; Kupcinskas J; Skieceviciene J; Link A
    World J Gastroenterol; 2023 Feb; 29(7):1202-1218. PubMed ID: 36926663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of microbial signatures between paired faecal and rectal biopsy samples from healthy volunteers using next-generation sequencing and culturomics.
    Mukhopadhya I; Martin JC; Shaw S; McKinley AJ; Gratz SW; Scott KP
    Microbiome; 2022 Oct; 10(1):171. PubMed ID: 36242064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pregnancy vaginal microbiome trends and preterm birth.
    Stout MJ; Zhou Y; Wylie KM; Tarr PI; Macones GA; Tuuli MG
    Am J Obstet Gynecol; 2017 Sep; 217(3):356.e1-356.e18. PubMed ID: 28549981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy.
    Neyaz A; Husain N; Kumari S; Gupta S; Shukla S; Arshad S; Anand N; Chaturvedi A
    Histopathology; 2018 Oct; 73(4):622-633. PubMed ID: 29882997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia.
    Fenn D; Abdel-Aziz MI; van Oort PMP; Brinkman P; Ahmed WM; Felton T; Artigas A; Póvoa P; Martin-Loeches I; Schultz MJ; Dark P; Fowler SJ; Bos LDJ;
    Crit Care; 2022 Jul; 26(1):203. PubMed ID: 35794610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes.
    Bonanno L; Pavan A; Dieci MV; Di Liso E; Schiavon M; Comacchio G; Attili I; Pasello G; Calabrese F; Rea F; Favaretto A; Rugge M; Guarneri V; Fassan M; Conte PF
    Eur J Cancer; 2018 Sep; 101():191-200. PubMed ID: 30077124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary Glands.
    Hiss S; Eckstein M; Segschneider P; Mantsopoulos K; Iro H; Hartmann A; Agaimy A; Haller F; Mueller SK
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33669038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients.
    Ren M; Dai B; Kong YY; Lv JJ; Cai X
    Histopathology; 2018 Sep; 73(3):386-396. PubMed ID: 29637587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
    Cortes J; Cescon DW; Rugo HS; Nowecki Z; Im SA; Yusof MM; Gallardo C; Lipatov O; Barrios CH; Holgado E; Iwata H; Masuda N; Otero MT; Gokmen E; Loi S; Guo Z; Zhao J; Aktan G; Karantza V; Schmid P;
    Lancet; 2020 Dec; 396(10265):1817-1828. PubMed ID: 33278935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PD-1/PD-L1 signaling pathway on intestinal flora in patients with colorectal cancer.
    Pi H; Huang L; Liu H; Liang S; Mei J
    Cancer Biomark; 2020; 28(4):529-535. PubMed ID: 32568184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterogeneity in PD-L1 expression on infiltrating immune cells between the primary and metastatic breast cancers].
    Wang XR; Zhang NN; Lyu F; Wang HL; Liu YP
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):430-434. PubMed ID: 32392925
    [No Abstract]   [Full Text] [Related]  

  • 19. Hot topic: 16S rRNA gene sequencing reveals the microbiome of the virgin and pregnant bovine uterus.
    Moore SG; Ericsson AC; Poock SE; Melendez P; Lucy MC
    J Dairy Sci; 2017 Jun; 100(6):4953-4960. PubMed ID: 28434745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT).
    Tufman A; Neumann J; Manapov F; Sellmer L; Jung A; Kauffmann-Guerrero D; Kahnert K; Mertsch P; Borgmeier A; Semrau S; Rittmeyer A; Ulm B; Ulm K; Flentje M; Fietkau R; Huber RM
    Lung Cancer; 2021 Oct; 160():17-27. PubMed ID: 34371299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.